Excluded from today's screen — already covered in the last 7 days.
| Company | Researched on |
|---|---|
| CAPCOM CO LTD (9697) | 2026-06-04 |
| TOKYO METRO CO LTD (9023) | 2026-06-05 |
| DAIICHI SANKYO COMPANY LIMITED (4568) | 2026-06-06 |
| SKYLARK HOLDINGS CO LTD (3197) | 2026-06-07 |
| EUGLENA CO LTD (2931) | 2026-06-08 |
| NTT INC (9432) | 2026-06-09 |
| Company | Opportunity | Core moat damage | Rationale |
|---|---|---|---|
| ONCOTHERAPY SCIENCE INC (4564) | 2 | 8 | Precision-medicine/service differentiation looks structurally impaired, and pipeline value is decaying under delays, burn, and patent-life slippage. Upside depends on low-visibility clinical or licensing wins while dilution risk compounds. |
| JFE HOLDINGS INC (5411) Selected | 7 | 4 | High-grade steel qualification, domestic scale, and customer relationships appear intact; current pain is mainly cyclical spread compression plus some structural trade friction. Rebound upside is meaningful, though leverage and protectionism limit true convexity. |
| ENISH INC (3667) | 1 | 9 | Its scale/data flywheel, licensor trust, and talent density are structurally eroding under going-concern stress, resettable dilution, and the crypto-treasury detour. Any hit-driven upside is heavily diluted and path-dependent. |
| CAICA DIGITAL INC (2315) | 3 | 6 | Legacy SI switching costs survive, but brand and trust have been weakened by weak core profits, crypto volatility, and restatements, while the Nexs impairment permanently hurt moat-building plans. Upside needs simultaneous governance and execution repair. |
| MEDINET CO LTD (2370) | 2 | 7 | Process know-how remains, but client continuity and trust are weakened by cash burn, dilution, and a tighter regulatory backdrop that reduces scalable demand. Fixed-cost deleverage and financing mechanics make downside compounding. |
| KAIHAN CO LTD (3133) | 1 | 7 | The only tangible moat, local restaurant execution and density, is being undermined by acute financial distress, while the newer businesses never formed real moats. Covenant stress, penalties, and capital needs create a very fat left tail. |
| MODALIS THERAPEUTICS CORP (4883) | 4 | 5 | Core platform IP is not broken, but delays, single-asset dependence, and financing overhang erode effective exclusivity and per-share upside. Theoretical upside is large if proof-of-concept arrives, yet current equity math remains negative-convex. |
| CHIOME BIOSCIENCE INC (4583) | 5 | 4 | The scientific platform and partner credibility are weakened mainly by delay and underinvestment, not by a clear technical moat break. Dealability is proven, but burn and dilution still shift too much value away from current holders. |
| BIRDMAN INC (7063) | 1 | 9 | Its trust and talent moat has been structurally damaged by funding-driven execution failures and going-concern flags, and the EX/IP side has effectively reset. Turnaround upside is subordinate to survival and recap dilution. |
| AIMING INC (3911) | 5 | 4 | Partner and IP access appears intact, and live-ops weakness looks more title-specific than permanently impaired. A successful launch could re-rate earnings, but structural moats remain thin and the business stays hit-driven. |
| REMIXPOINT INC (3825) | 2 | 6 | There was little moat to begin with, and the crypto pivot, volatile marks, and ratcheting dilution impair the odds of building a real energy or storage advantage. Upside is mostly exogenous crypto beta rather than durable business improvement. |
| ANGES INC (4563) | 4 | 6 | Japan withdrawal permanently erased the only real commercial foothold, but U.S. regulatory optionality still offers contingent upside if approval occurs. For current equity holders, ongoing burn and dilution capture too much of that future value. |
| SYMBIO PHARMACEUTICALS LTD (4582) | 2 | 10 | The legacy Treakisym moat has been structurally destroyed by generic entry and price cuts, and BCV is only a prospective replacement. Shrinking cash flows plus funding dependence make the equity claim highly concave. |
| NFK HOLDINGS (6494) | 6 | 3 | Core engineering know-how and installed-base relationships look intact; current weakness is mostly backlog timing and a non-core restructuring loss. Downside is more bounded than most here, though secular combustion pressure and earnings leakage cap upside. |
| CRAVIA INC (6573) | 1 | 7 | Thin relationship and network advantages are being weakened by going-concern risk, client churn, and repeated dilution, while new moat formation requires capital the business does not have. Upside from vending rollout is capital-gated and heavily path-dependent. |
Why this company was selected: JFE is the best risk-adjusted opportunity in this set because its core qualification, scale, and customer-relationship moat is still intact while current pain is mostly cyclical and operational rather than a true moat break. Most alternatives face structural moat damage plus financing loops that confiscate upside; JFE still retains meaningful rebound earnings power if spreads and utilization normalize.
JFE Holdings is Japan’s second-largest steel group. It owns JFE Steel, JFE Engineering, and JFE Shoji, so the group is not just a mill operator: it also has an engineering arm tied to energy, environment, waste-to-resource, and infrastructure projects, plus a trading arm that distributes steel and other materials. Still, the economic center of gravity remains steel. If the steel spread is bad, the group’s return profile deteriorates quickly.
Data freshness matters here. The latest clean official annual base is the year ended March 2025. More recent data is the year ended March 2026 earnings release, which is official and full-year but still unaudited pending the annual securities report. Current share price and market capitalization are market-data snapshots from around early June 2026.
| Core number | Value | Classification |
|---|---|---|
| Market capitalization | About ¥1.00 trillion | Market-data estimate, around 2026-06-09 |
| Net cash / (net debt) | About (¥1.79 trillion) | Official full-year earnings release for year ended 2026-03-31, unaudited; based on management’s interest-bearing debt definition |
| Net income, TTM | ¥70.2 billion | Official full-year earnings release for year ended 2026-03-31, unaudited |
| Current P/E | About 14-15x | Market-data estimate on TTM EPS |
The first thing to understand is that this is not a cash-rich bargain sitting on an idle balance sheet. The equity is worth roughly ¥1.0 trillion, but it sits under roughly ¥1.8 trillion of net debt. So the stock’s cheap-looking asset value and dividend yield need to be judged against heavy operating leverage, financial leverage, and recurring capital intensity.
JFE makes money in three ways. The steel business produces flat steel, plate, pipes, and other steel products for autos, construction, shipbuilding, energy, and industrial customers. The engineering business executes projects in waste-to-energy, energy, environmental systems, steel structures, and offshore wind-related areas. The trading business distributes steel, raw materials, and other products. The steel unit drives most of the revenue and almost all of the capital needs; engineering and trading make the group less fragile, but they do not transform it into an asset-light compounder.
The latest full-year segment picture, from the official but unaudited year ended March 2026 earnings release, looks like this:
| Segment | Revenue | Segment profit | What matters |
|---|---|---|---|
| Steel | ¥3.09 trillion | ¥38.0 billion | Still the core franchise, but current profitability is very low relative to the asset base |
| Engineering | ¥0.60 trillion | ¥24.0 billion | Steadier and currently more supportive than many investors assume |
| Trading | ¥1.33 trillion | ¥40.2 billion | A real stabilizer in down-cycles, though not a moat-like source of returns |
Economics. At today’s quote the stock trades at roughly 14-15x TTM earnings. On company guidance for the year ending March 2027, it is closer to 6.7x. On my own normalized net income estimate of roughly ¥120-130 billion, it is about 8-9x. That tells you the stock looks cheap if you believe in a recovery, but not obviously mispriced if you think the recent low-return profile is the new normal.
Growth. There is no clean compounding story here. If you use the latest official full-year trend, revenue fell from ¥5.27 trillion in the year ended March 2023 to ¥4.54 trillion in the year ended March 2026, roughly a 5% annual decline. EPS fell from ¥281 to ¥110 over the same period. If you stretch back five years, revenue growth looks much better, but that mainly reflects recovery from the pandemic trough, price/mix, and yen effects rather than durable volume growth. The two concrete drivers behind what growth there has been are straightforward: first, steel price and mix recovery in better years; second, stronger engineering execution, including energy and infrastructure-related work. Crude steel volumes themselves are not compounding.
Owner earnings sanity check. For a steelmaker, the literal shortcut of net income minus capex is misleading because depreciation is huge. The more useful test is operating cash flow minus estimated sustaining capex. Using the audited year ended March 2025 as the clean base:
| Owner-earnings bridge | Amount | Classification |
|---|---|---|
| Net income | ¥91.9 billion | Audited annual data |
| Plus depreciation and amortization | ¥257.6 billion | Audited annual data |
| Less sustaining capex | ¥240-270 billion | Own estimate |
| Plus / minus working capital | Roughly flat to modestly favorable | Own estimate |
| Rough owner earnings | About ¥80-110 billion | Own estimate |
| Owner earnings yield at current market cap | About 8-11% | Own estimate versus market-data estimate |
This is somewhat better than the TTM P/E implies, but not dramatically so. The reason is simple: depreciation is large, but so is maintenance capex. JFE is cheaper on normalized cash earnings than on depressed TTM earnings, yet it is not the kind of business where low P/E automatically means abundant owner cash.
Capital efficiency. ROE has ranged from deeply negative in bad years to the mid-teens in peak years, but the more relevant recent range is only about 3-9%, with management’s latest year ended March 2026 update at roughly 2.7%. Audited ROIC for the year ended March 2025 was only mid-single-digit. Incremental capital is not earning high returns through the cycle. That is the central reason the stock can remain optically cheap for long periods.
Business quality. JFE has real barriers: integrated mills, port access, process know-how, customer qualification in demanding products, and a trading and engineering ecosystem that would take years to recreate. But this is mostly a time-and-scale moat, not a high-pricing-power moat. In strong steel markets, the business can look excellent. Through the cycle, it is better described as strategically important and hard to replicate than consistently great for minority shareholders.
The stock traded around ¥1,575 in early June 2026, versus a 52-week high of roughly ¥2,359 in February 2026. That is a drawdown of about one-third, and it put the shares essentially back at their 52-week low.
The decline is not about a single blow-up event. It is the market progressively lowering its estimate of JFE’s sustainable earning power. Net income fell from ¥197.4 billion in the audited year ended March 2024 to ¥91.9 billion in the audited year ended March 2025, then to ¥70.2 billion in the official but unaudited year ended March 2026 earnings release. The dividend was reset from ¥100 per share to ¥80. Debt rose. Management also made it plain that even the year ending March 2027 recovery would still leave profitability below the original medium-term plan. So the stock is near its low because investors do not trust that the next rebound will restore attractive returns on capital.
In plain English, the market is treating JFE less like a temporarily weak steel cyclical and more like a structurally lower-return industrial that still needs to spend heavily just to stay competitive.
(a) One-time / cyclical / sentiment-driven factors
(b) Medium-term business headwinds
(c) Potential long-term structural threats
Reality check versus the market narrative.
| Concern | Quantitative reality over 2+ years | My reading |
|---|---|---|
| The group is collapsing | Revenue went from ¥5.17 trillion in the year ended March 2024 to ¥4.86 trillion in the year ended March 2025 and ¥4.54 trillion in the year ended March 2026. | This is a real downturn, not a collapse. JFE is earning much less, but the revenue base is still enormous and diversified. |
| Core profitability has disappeared | Net income fell from ¥197.4 billion to ¥91.9 billion to ¥70.2 billion across those same three years. But management’s business profit was ¥135.3 billion in the year ended March 2025 and ¥135.4 billion in the year ended March 2026, while business profit excluding inventory effects fell from ¥236.3 billion to ¥166.3 billion. | The headline decline overstates the damage because one-offs and inventory effects matter. Still, the underlying steel economics did weaken materially. |
| Cash generation is broken | Operating cash flow was ¥479.0 billion in the year ended March 2024, ¥379.0 billion in the year ended March 2025, and ¥379.1 billion in the year ended March 2026. | Cash flow is still positive and meaningful. The real problem is that capital intensity and investment demands absorb too much of it. |
| Non-steel businesses do not matter | Engineering revenue rose from ¥524.7 billion to ¥554.2 billion to ¥599.8 billion over the last three reported years. Trading segment profit was ¥49.0 billion, then ¥48.0 billion, then ¥40.2 billion. | The non-steel segments are real stabilizers. They do not turn JFE into a great business, but they do stop it from being a pure steel knife-edge. |
| The balance sheet is close to distress | Equity ratio was 42.8% in the year ended March 2024, 44.8% in the year ended March 2025, and 44.4% in the year ended March 2026. But interest-bearing debt rose from ¥1.77 trillion to ¥1.96 trillion, and debt/EBITDA rose from 4.5x to 4.8x. | Not distressed, but clearly not conservative. The balance sheet is survivable, not comfortable. |
| Volumes will bounce back soon | Year ended March 2026 crude steel output fell 2.8% year on year and shipments fell 2.6%. Management guides roughly 21.5 million tons next year and plans to reduce domestic capacity from 26 million tons to 21 million tons by FY2028. | This is the biggest clue that some of the problem is structural, not just cyclical. |
Structural diagnosis.
| Structural concern | Damaged mechanism | Does it damage core value creation and moat? | Can 3 years realistically heal it? | Classification |
|---|---|---|---|---|
| Secular decline in Japanese steel demand | Domestic mill utilization and fixed-cost absorption | Yes. Lower domestic demand directly hurts the economics of an integrated blast-furnace system. It does not erase JFE’s customer relationships, but it weakens returns on the domestic asset base. | No, not domestically. JFE can only offset it through capacity cuts, mix improvement, exports, and overseas growth. | (b) Real structural but survivable |
| China overcapacity and trade fragmentation | Regional price umbrella and export spreads | Yes. This weakens pricing power in commodity and semi-commodity steel. It does not destroy JFE’s technical niches, but it compresses what those niches can earn. | Unlikely. This looks persistent rather than a normal one-cycle issue. | (b) Real structural but survivable |
| Decarbonization and modernization capex | Incremental ROIC and balance-sheet flexibility | Yes. The main damage is not current revenue; it is the risk that future reinvestment earns mediocre returns while debt stays elevated. | No. These projects are long-cycle and capital intensive. | (b) Real structural but survivable |
| Material substitution in some end markets | Share of demand in autos and lightweight applications | Only partly. JFE still benefits from high-tensile steel and qualified products. This is not the main driver of current weakness. | Mostly yes, through adaptation and mix. | (c) Not truly structural |
Overall diagnosis: the current earnings slump is mostly TIME; the low through-cycle return profile is ESSENCE. The market is probably too negative on the former, but it is not wrong on the latter.
Time-as-a-moat test.
| Horizon | Could you rebuild a competing JFE with today’s market cap in cash? | What would still block you? |
|---|---|---|
| 2 years | No | Permits, land, environmental approvals, blast furnace or EAF construction timelines, port logistics, customer qualification, and skilled labor. |
| 5 years | Still no full equivalent | You might build a smaller mill or a trading operation, but not an integrated steel-engineering-trading platform with JFE’s customer approvals and installed base. |
| 10 years | Partially, but not economically identical | You could replicate pieces of it, especially with newer EAF-heavy assets, but not the same product breadth, trust, ecosystem, and qualification history without spending more than today’s equity value and waiting years. |
So there is a moat here, but it is mostly a moat of time, regulation, engineering complexity, and customer trust. The catch is crucial: a hard-to-rebuild business is not automatically a high-return business. JFE’s market discount exists because investors doubt the return on that asset base, not because they think the assets are easy to copy.
Valuation basis. This is a year ended March 2025 audited valuation adjusted with the year ended March 2026 full-year earnings release and current market data. I am valuing the equity on normalized owner earnings, not on EV/EBITDA. Because owner earnings are post-interest cash flow to equity, I do not apply a separate net debt adjustment in the bridge; leverage instead shows up in the lower cash earnings and the higher yield I require. This is an intrinsic value estimate, not a price target.
| Case | Owner earnings base | Normalization assumption | Required equity yield | Implied equity value | Implied value per share | Upside / downside vs. ~¥1,575 |
|---|---|---|---|---|---|---|
| Bear | ¥70 billion | Steel recovery stalls; sustaining capex proves closer to total capex; weak spreads persist | 10.0% | ¥0.70 trillion | About ¥1,100/share | About -30% |
| Base | ¥100 billion | Steel recovers somewhat; engineering and trading stay resilient; no heroic volume rebound | 9.0% | ¥1.11 trillion | About ¥1,745/share | About +11% |
| Bull | ¥130 billion | Price hikes stick; non-steel remains firm; overseas and mix help; no major oil/geopolitical shock | 8.0% | ¥1.63 trillion | About ¥2,555/share | About +62% |
At the current market cap of about ¥1.00 trillion, the stock implies roughly a 10% owner-earnings yield on my base ¥100 billion estimate. I would require about a 9% yield to own a business like this. That gap is real, but modest: it points to something like ¥100 billion of equity undervaluation, or roughly ¥170 per share, not to a huge disconnect.
My conclusion is that the market is a little too pessimistic, but not irrational. JFE is not priced for prosperity, yet neither is it a clear fat-pitch bargain once you account for debt, maintenance needs, and structurally weaker domestic steel economics.
Moat & Mispricing Score: 5/10. JFE has a real moat of time, scale, qualification, and industrial complexity. What it does not have is strong through-cycle pricing power or high incremental returns on capital. The market is probably getting one thing wrong: it is leaning too hard on today’s weak steel spreads and too lightly on the resilience of operating cash flow and the engineering/trading businesses. But the market is getting the big thing right: this is not a high-return compounder, and some of the earnings damage is genuinely structural. The shares look modestly undervalued, not dramatically mispriced.
CoffeeAnd — 52-week low lens